ANI: Our technology is now “recommended” in ICU.
A new publication “Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU” is “recommending” the use of our Analgesia Nociception Index (ANI) in the Intensive Care Unit (ICU).
Good things come in pairs though.
Indeed, Medasense, a company working in the medical field, is recognizing the benefit of using ANI, our technology, in its presentation at the SFAR (Société Française d’Anesthésie et Réanimation) convention today.
With this presentation, we have a second voice backing our company today.
You can read the article “Intraoperative Analgesia Nociception Index – Guided Fentanyl Administration During Sevoflurane Anesthesia in Lumbar Discectomy and Laminectomy: A Randomized Clinical Trial”, below:
Perfect to start the weekend on a good note!